未登录

B

Basak Tas

University of London

H指数:9

被引数:244

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recent Innovations to Detect and Intervene to Prevent Opioid Overdose Deaths

待发表——近期检测并干预以预防阿片类药物滥用的创新措施

BRITISH JOURNAL OF HOSPITAL MEDICINE

IF1.8

2025-10-250

PRE

Development of Novel Wearable Biosensor for Continuous Monitoring of Central Body Motion

新型可穿戴生物传感器用于持续监测躯体运动的开发

APPLIED SCIENCES-BASEL

IF2.5

2025-10-140

OAAI

Analysis of rapid onset heroin overdose cases from a supervised injecting facility in Melbourne, Australia

对澳大利亚墨尔本一家监督注射设施中快速发作的海洛因过量病例的分析

IF5.3

2025-09-260

OAAI

A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine-treated population?

IF5.3

2025-02-100

OA

What impacts the acceptability of wearable devices that detect opioid overdose in people who use opioids? A qualitative study

DRUG AND ALCOHOL REVIEW

IF2.6

2023-08-192

OA

A scoping review of mHealth technologies for opioid overdose prevention, detection and response

DRUG AND ALCOHOL REVIEW

IF2.6

2023-03-1810

OA

Risk factors for respiratory depression in Opioid Use Disorder

EUROPEAN RESPIRATORY JOURNAL

IF21

2022-12-010

PRE

Undetected Respiratory Depression in People with Opioid Use Disorder

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-05-013

OAAI

Could COVID expand the future of addiction research? Long-term implications in the pandemic era

IF5.3

2022-01-258

OA

RESPIRATORY DEPRESSION IN OPIOID DEPENDENT CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS

IF7.7

2021-11-080

OA

Heroin-induced respiratory depression and the influence of dose variation: within-subject between-session changes following dose reduction

IF5.3

2020-03-1117

OAAI

Should we worry that take-home naloxone availability may increase opioid use?

我们是否应该担心纳洛酮带回家可能会增加阿片类药物的使用？

IF5.3

2019-06-1210

OAAI

An observational study of the severity of respiratory depression (RDP) in opioid dependent patients (ODP)

EUROPEAN RESPIRATORY JOURNAL

IF21

2017-12-060

PRE

THE PREVALENCE OF RESPIRATORY SYMPTOMS AND LUNG DISEASE IN A SOUTH LONDON LUNG HEALTH IN ADDICTIONS SERVICE

IF7.7

2016-11-152

OAAI

Commentary on Darke & Duflou (2016): Heroin-related deathsidentifying a window for intervention

IF5.3

2016-08-123

OAAI

Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?

IF5.3

2016-02-0338

PREAI